Delivery Order SPE2DB24D2011-SPE2DB25FBRGN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for NURTEC ODT 75 mg tablets in quantities of eight units, valued at $6,465.10. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of August 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,461.79 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $10,377.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The award, issued without a set-aside designation, reflects open competition and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. Performance will be completed by July 15, 2025, with fulfillment based at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,366.42 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price delivery order valued at $27,389.85, with an ultimate completion date of July 15, 2025. The award was made through competitive procedures with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $114.5K to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This non-competitive, firm fixed-price delivery order, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a continuation of the federal pharmaceutical supply chain supporting military and veteran healthcare systems. The contract will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,700.47 for NURTEC ODT 75 mg tablets (8-count units) on August 25, 2025, with completion anticipated by August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRGNDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,630.69 on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs worldwide. NURTEC ODT is a migraine treatment medication, consistent with the vendor's extensive portfolio of specialty neurological pharmaceuticals and medical supplies supporting Defense Health Agency and other federal healthcare customers. The structure of this delivery order exemplifies the DLA's approach to leveraging prime vendor contracts for efficient procurement of critical pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 7/14/25 |